US Stock MarketDetailed Quotes

Enveric Biosciences (ENVB)

Watchlist
  • 4.265
  • +0.005+0.12%
Trading Jan 23 14:16 ET
4.36MMarket Cap-0.05P/E (TTM)

Enveric Biosciences (ENVB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.04%1.87M
32.73%2.52M
-11.70%2.19M
-47.36%9.63M
-25.01%3.17M
-39.59%2.08M
-67.02%1.9M
-49.03%2.48M
-8.34%18.3M
-11.86%4.23M
Selling and administrative expenses
19.70%1.43M
-2.33%1.22M
-27.87%1.36M
-39.69%6.45M
-12.48%2.12M
-42.53%1.2M
-61.86%1.25M
-36.04%1.89M
-7.80%10.7M
-14.00%2.43M
-General and administrative expense
19.70%1.43M
-2.33%1.22M
-27.87%1.36M
-39.69%6.45M
-12.48%2.12M
-42.53%1.2M
-61.86%1.25M
-36.04%1.89M
-7.80%10.7M
-14.00%2.43M
Research and development costs
-49.87%402.42K
123.02%1.26M
47.46%746.37K
-60.82%2.84M
-43.79%967.4K
-37.36%802.72K
-76.41%565K
-72.28%506.16K
-9.66%7.25M
-9.10%1.72M
Depreciation amortization depletion
-52.40%40.37K
-52.84%39.98K
-5.13%81.02K
-1.89%337.49K
-2.59%82.49K
-1.72%84.81K
-2.01%84.78K
-1.25%85.41K
4.90%343.98K
-2.10%84.68K
-Depreciation and amortization
-52.40%40.37K
-52.84%39.98K
-5.13%81.02K
-1.89%337.49K
-2.59%82.49K
-1.72%84.81K
-2.01%84.78K
-1.25%85.41K
4.90%343.98K
-2.10%84.68K
Operating profit
10.04%-1.87M
-32.73%-2.52M
11.70%-2.19M
47.36%-9.63M
25.01%-3.17M
39.59%-2.08M
67.02%-1.9M
49.03%-2.48M
8.34%-18.3M
11.86%-4.23M
Net non-operating interest income expense
226.27%274
-277.14%-132
-99.71%2
-94.09%219
-139.75%-225
-109.70%-217
-103.82%-35
6,427.27%696
170.64%3.71K
519.26%566
Non-operating interest income
----
----
----
-94.09%219
----
----
----
----
--3.71K
----
Total other finance cost
-226.27%-274
277.14%132
99.71%-2
----
----
109.70%217
103.82%35
-6,427.27%-696
----
----
Other net income (expense)
-88.03%2.57K
-93.59%65.99K
-96.75%26.6K
-100.10%-623
103.09%18.57K
-88.30%21.44K
10,976.86%1.03M
115.26%818.41K
Gain on sale of security
----
----
----
-95.54%45.99K
-99.19%6.6K
-100.10%-623
103.09%18.57K
-88.30%21.44K
-86.20%1.03M
-60.88%818.41K
Other non- operating income (expenses)
----
----
-88.03%2.57K
--20K
---19.39K
---623
--18.57K
--21.44K
----
----
Income before tax
10.09%-1.87M
-34.04%-2.52M
11.01%-2.18M
44.59%-9.57M
7.80%-3.15M
25.98%-2.08M
70.43%-1.88M
47.51%-2.46M
13.50%-17.26M
66.41%-3.41M
Income tax
0
0
0
-69.11%8.93K
-67.74%7.2K
0
0
1.73K
101.95%28.91K
101.50%22.32K
Net income
10.09%-1.87M
-34.04%-2.52M
11.07%-2.18M
44.63%-9.57M
8.19%-3.15M
26.16%-2.08M
70.43%-1.88M
47.47%-2.46M
6.39%-17.29M
60.41%-3.44M
Net income continuous Operations
10.09%-1.87M
-34.04%-2.52M
11.07%-2.18M
44.63%-9.57M
8.19%-3.15M
26.16%-2.08M
70.43%-1.88M
47.47%-2.46M
6.39%-17.29M
60.41%-3.44M
Minority interest income
0
0
0
0
0
-42.32%19.04K
0
Net income attributable to the parent company
10.09%-1.87M
-34.04%-2.52M
11.07%-2.18M
44.69%-9.57M
8.19%-3.15M
26.16%-2.08M
70.46%-1.88M
47.61%-2.46M
6.45%-17.31M
60.46%-3.44M
Preferred stock dividends
1.51M
-50.00%147.99K
0
Other preferred stock dividends
Net income attributable to common stockholders
-62.53%-3.39M
-34.04%-2.52M
11.07%-2.18M
45.16%-9.57M
8.19%-3.15M
26.16%-2.08M
70.63%-1.88M
48.82%-2.46M
7.14%-17.46M
60.96%-3.44M
Basic earnings per share
74.92%-129.72
73.92%-11.64
86.75%-14.64
84.30%-228.4799
78.84%-55.8344
-121.03%-517.2
91.84%-44.64
73.42%-110.52
37.80%-1.46K
70.02%-263.88
Diluted earnings per share
74.92%-129.72
73.92%-11.64
86.75%-14.64
84.30%-228.4799
78.84%-55.8344
-121.03%-517.2
91.84%-44.64
73.42%-110.52
37.80%-1.46K
70.02%-263.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.04%1.87M32.73%2.52M-11.70%2.19M-47.36%9.63M-25.01%3.17M-39.59%2.08M-67.02%1.9M-49.03%2.48M-8.34%18.3M-11.86%4.23M
Selling and administrative expenses 19.70%1.43M-2.33%1.22M-27.87%1.36M-39.69%6.45M-12.48%2.12M-42.53%1.2M-61.86%1.25M-36.04%1.89M-7.80%10.7M-14.00%2.43M
-General and administrative expense 19.70%1.43M-2.33%1.22M-27.87%1.36M-39.69%6.45M-12.48%2.12M-42.53%1.2M-61.86%1.25M-36.04%1.89M-7.80%10.7M-14.00%2.43M
Research and development costs -49.87%402.42K123.02%1.26M47.46%746.37K-60.82%2.84M-43.79%967.4K-37.36%802.72K-76.41%565K-72.28%506.16K-9.66%7.25M-9.10%1.72M
Depreciation amortization depletion -52.40%40.37K-52.84%39.98K-5.13%81.02K-1.89%337.49K-2.59%82.49K-1.72%84.81K-2.01%84.78K-1.25%85.41K4.90%343.98K-2.10%84.68K
-Depreciation and amortization -52.40%40.37K-52.84%39.98K-5.13%81.02K-1.89%337.49K-2.59%82.49K-1.72%84.81K-2.01%84.78K-1.25%85.41K4.90%343.98K-2.10%84.68K
Operating profit 10.04%-1.87M-32.73%-2.52M11.70%-2.19M47.36%-9.63M25.01%-3.17M39.59%-2.08M67.02%-1.9M49.03%-2.48M8.34%-18.3M11.86%-4.23M
Net non-operating interest income expense 226.27%274-277.14%-132-99.71%2-94.09%219-139.75%-225-109.70%-217-103.82%-356,427.27%696170.64%3.71K519.26%566
Non-operating interest income -------------94.09%219------------------3.71K----
Total other finance cost -226.27%-274277.14%13299.71%-2--------109.70%217103.82%35-6,427.27%-696--------
Other net income (expense) -88.03%2.57K-93.59%65.99K-96.75%26.6K-100.10%-623103.09%18.57K-88.30%21.44K10,976.86%1.03M115.26%818.41K
Gain on sale of security -------------95.54%45.99K-99.19%6.6K-100.10%-623103.09%18.57K-88.30%21.44K-86.20%1.03M-60.88%818.41K
Other non- operating income (expenses) ---------88.03%2.57K--20K---19.39K---623--18.57K--21.44K--------
Income before tax 10.09%-1.87M-34.04%-2.52M11.01%-2.18M44.59%-9.57M7.80%-3.15M25.98%-2.08M70.43%-1.88M47.51%-2.46M13.50%-17.26M66.41%-3.41M
Income tax 000-69.11%8.93K-67.74%7.2K001.73K101.95%28.91K101.50%22.32K
Net income 10.09%-1.87M-34.04%-2.52M11.07%-2.18M44.63%-9.57M8.19%-3.15M26.16%-2.08M70.43%-1.88M47.47%-2.46M6.39%-17.29M60.41%-3.44M
Net income continuous Operations 10.09%-1.87M-34.04%-2.52M11.07%-2.18M44.63%-9.57M8.19%-3.15M26.16%-2.08M70.43%-1.88M47.47%-2.46M6.39%-17.29M60.41%-3.44M
Minority interest income 00000-42.32%19.04K0
Net income attributable to the parent company 10.09%-1.87M-34.04%-2.52M11.07%-2.18M44.69%-9.57M8.19%-3.15M26.16%-2.08M70.46%-1.88M47.61%-2.46M6.45%-17.31M60.46%-3.44M
Preferred stock dividends 1.51M-50.00%147.99K0
Other preferred stock dividends
Net income attributable to common stockholders -62.53%-3.39M-34.04%-2.52M11.07%-2.18M45.16%-9.57M8.19%-3.15M26.16%-2.08M70.63%-1.88M48.82%-2.46M7.14%-17.46M60.96%-3.44M
Basic earnings per share 74.92%-129.7273.92%-11.6486.75%-14.6484.30%-228.479978.84%-55.8344-121.03%-517.291.84%-44.6473.42%-110.5237.80%-1.46K70.02%-263.88
Diluted earnings per share 74.92%-129.7273.92%-11.6486.75%-14.6484.30%-228.479978.84%-55.8344-121.03%-517.291.84%-44.6473.42%-110.5237.80%-1.46K70.02%-263.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More